PRE 14A

CHROMADEX SCHEDULE 14A

Company: Niagen Bioscience, Inc.
Filed: August 29, 2011
Period of Report: August 29, 2011
Accession Number: 0001415889-11-000877

View Document ↗ View on SEC.gov ↗